Denmark Drops AstraZeneca Vaccine Permanently Over Suspected Side Effects
Denmark was the first country in Europe to suspend the use of the AstraZeneca jab in its vaccination rollout, after reports of rare but serious cases of blood clots among those that had received the vaccine.
Denmark announced Tuesday it would stop using the AstraZeneca Covid-19 vaccine altogether, becoming the first European country to do so over suspected rare but serious side effects.
Despite recommendations from the World Health Organization and European medicines watchdog to continue using the inoculation, "Denmark's vaccination campaign will go ahead without the AstraZeneca vaccine," Health Authority director Soren Brostrom told a press conference.
Denmark was the first country in Europe to suspend the use of the AstraZeneca jab in its vaccination rollout, after reports of rare but serious cases of blood clots among those that had received the vaccine.
More than a dozen countries followed suit but all but a few have since resumed the use after the European Medicines Agency (EMA) emphasised the benefits of the vaccine and deemed it "safe and effective".
Denmark had however continued to hold off using the vaccine as it conducted investigations of its own.
In Denmark, two cases of thrombosis, one of which was fatal, were linked to vaccinations after more than 140,000 people received the jab made by the Anglo-Swedish drugmaker.
In the country of 5.8 million inhabitants, eight percent have been fully vaccinated against Covid-19, and 17 percent have received a first dose.
Since suspending use of the AstraZeneca jab in March, Denmark has continued with the Pfizer/BioNTech and Moderna jabs.
The AstraZeneca suspension delays the country's ambitious vaccine rollout plans, but the health authority said in a statement that the availability of other vaccines combined with the pandemic being under control at the moment meant the inoculation campaign could continue without it.
Despite recommendations from the World Health Organization and European medicines watchdog to continue using the inoculation, "Denmark's vaccination campaign will go ahead without the AstraZeneca vaccine," Health Authority director Soren Brostrom told a press conference.
Denmark was the first country in Europe to suspend the use of the AstraZeneca jab in its vaccination rollout, after reports of rare but serious cases of blood clots among those that had received the vaccine.
More than a dozen countries followed suit but all but a few have since resumed the use after the European Medicines Agency (EMA) emphasised the benefits of the vaccine and deemed it "safe and effective".
Denmark had however continued to hold off using the vaccine as it conducted investigations of its own.
In Denmark, two cases of thrombosis, one of which was fatal, were linked to vaccinations after more than 140,000 people received the jab made by the Anglo-Swedish drugmaker.
In the country of 5.8 million inhabitants, eight percent have been fully vaccinated against Covid-19, and 17 percent have received a first dose.
Since suspending use of the AstraZeneca jab in March, Denmark has continued with the Pfizer/BioNTech and Moderna jabs.
The AstraZeneca suspension delays the country's ambitious vaccine rollout plans, but the health authority said in a statement that the availability of other vaccines combined with the pandemic being under control at the moment meant the inoculation campaign could continue without it.
AI Disclaimer: An advanced artificial intelligence (AI) system generated the content of this page on its own. This innovative technology conducts extensive research from a variety of reliable sources, performs rigorous fact-checking and verification, cleans up and balances biased or manipulated content, and presents a minimal factual summary that is just enough yet essential for you to function as an informed and educated citizen. Please keep in mind, however, that this system is an evolving technology, and as a result, the article may contain accidental inaccuracies or errors. We urge you to help us improve our site by reporting any inaccuracies you find using the "Contact Us" link at the bottom of this page. Your helpful feedback helps us improve our system and deliver more precise content. When you find an article of interest here, please look for the full and extensive coverage of this topic in traditional news sources, as they are written by professional journalists that we try to support, not replace. We appreciate your understanding and assistance.
